Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients’ Satisfaction and Cost Analysis. A Cohort Study in IBD Patients

Open Access

Peer-reviewed

Research Article

S. Mazzuoli,

Affiliation Gastroenterology & Artificial Nutrition Dept., “San Nicola Pellegrino” Hospital, Trani (BT), Italy
⨯
D. Tricarico,

Affiliation Department of Pharmacology and Pharmaceutical Sciences, University of Bari “Aldo Moro”, Bari, Italy
⨯
F. Demma,

Affiliation Health Economics & Outcome Research Department - EBMA Consulting, Milano, Italy
⨯
G. Furneri,

Affiliation Health Economics & Outcome Research Department - EBMA Consulting, Milano, Italy
⨯
F. W. Guglielmi

* E-mail: guglielmifw@libero.it

Affiliation Gastroenterology & Artificial Nutrition Dept., “San Nicola Pellegrino” Hospital, Trani (BT), Italy
⨯

Reader Comments (0)

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.
Nurses
Is the Subject Area "Nurses" applicable to this article?

Thanks for your feedback.
Ulcerative colitis
Is the Subject Area "Ulcerative colitis" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Forecasting
Is the Subject Area "Forecasting" applicable to this article?

Thanks for your feedback.
Hypotension
Is the Subject Area "Hypotension" applicable to this article?

Thanks for your feedback.